The preferred substrates for transglutaminase 2 in a complex wheat gluten digest are Peptide fragments harboring celiac disease T-cell epitopes.
BACKGROUND
Celiac disease is a T-cell mediated chronic inflammatory disorder of the gut that is induced by dietary exposure to gluten proteins. CD4+ T cells of the intestinal lesion recognize gluten peptides in the context of HLA-DQ2.5 or HLA-DQ8 and the gluten derived peptides become better T-cell antigens after deamidation catalyzed by the enzyme transglutaminase 2 (TG2). In this study we aimed to identify the preferred peptide substrates of TG2 in a heterogeneous proteolytic digest of whole wheat gluten.


METHODS
A method was established to enrich for preferred TG2 substrates in a complex gluten peptide mixture by tagging with 5-biotinamido-pentylamine. Tagged peptides were isolated and then identified by nano-liquid chromatography online-coupled to tandem mass spectrometry, database searching and final manual data validation.


RESULTS
We identified 31 different peptides as preferred substrates of TG2. Strikingly, the majority of these peptides were harboring known gluten T-cell epitopes. Five TG2 peptide substrates that were predicted to bind to HLA-DQ2.5 did not contain previously characterized sequences of T-cell epitopes. Two of these peptides elicited T-cell responses when tested for recognition by intestinal T-cell lines of celiac disease patients, and thus they contain novel candidate T-cell epitopes. We also found that the intact 9mer core sequences of the respective epitopes were not present in all peptide substrates. Interestingly, those epitopes that were represented by intact forms were frequently recognized by T cells in celiac disease patients, whereas those that were present in truncated versions were infrequently recognized.


CONCLUSIONS
TG2 as well as gastrointestinal proteolysis play important roles in the selection of gluten T-cell epitopes in celiac disease.
Centre for Immune Regulation, Institute of Immunology, University of Oslo, Oslo, Norway. siri.dorum@rr-research.no
Siri
S
Dørum
Magnus Ø
MØ
Arntzen
Shuo-Wang
SW
Qiao
Anders
A
Holm
Christian J
CJ
Koehler
Bernd
B
Thiede
Ludvig M
LM
Sollid
Burkhard
B
Fleckenstein
D000595:Amino Acid Sequence; D002446:Celiac Disease / Q000276:immunology* / Q000378:metabolism; D002853:Chromatography, Liquid; D018984:Epitopes, T-Lymphocyte / Q000276:immunology* / Q000378:metabolism; D019204:GTP-Binding Proteins / Q000235:genetics / Q000378:metabolism*; D005903:Gliadin / Q000276:immunology / Q000378:metabolism; D005983:Glutens / Q000737:chemistry / Q000276:immunology* / Q000378:metabolism; D006801:Humans; D013058:Mass Spectrometry; D036103:Nanotechnology / Q000379:methods; D010446:Peptide Fragments / Q000276:immunology / Q000378:metabolism; D010455:Peptides / Q000138:chemical synthesis / Q000276:immunology* / Q000378:metabolism; D000091345:Protein Glutamine gamma Glutamyltransferase 2; D011994:Recombinant Proteins / Q000378:metabolism; D013379:Substrate Specificity; D011503:Transglutaminases / Q000235:genetics / Q000378:metabolism*; D014908:Triticum / Q000276:immunology / Q000378:metabolism
D018984:Epitopes, T-Lymphocyte; D010446:Peptide Fragments; D010455:Peptides; D011994:Recombinant Proteins; D005983:Glutens; D005903:Gliadin; D000091345:Protein Glutamine gamma Glutamyltransferase 2; D011503:Transglutaminases; D019204:GTP-Binding Proteins